Skip to main content
Clinical Trials/NCT03706612
NCT03706612
Completed
Not Applicable

Shape Up! Kids Study

University of Hawaii3 sites in 1 country430 target enrollmentApril 1, 2017
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
University of Hawaii
Enrollment
430
Locations
3
Primary Endpoint
Fasting glucose levels
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Identify the unique associations of body shape to body composition and bone density indices in a pediatric population that represents the variance of sex, age, BMI-Z, and ethnicity found in the US population.

Describe the precision and accuracy of optical scans to monitor change in body composition, bone density and metabolic health interventions.

Estimate the level of association of optical to common health indicators including metabolic risk factors (glucose, triglycerides, HDL-cholesterol, blood pressure, VAT, WC and strength) by gender, race, age, and BMI-Z.

Investigate holistic, high-resolution descriptors of 3D body shape as direct predictors of body composition and metabolic risk using statistical shape models and Latent Class Analysis.

Registry
clinicaltrials.gov
Start Date
April 1, 2017
End Date
January 4, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University of Hawaii
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy participants will be included in the study if they have a self-reported ability to:
  • walk one-quarter of a mile and climb 10 steps without difficulty,
  • perform activities of daily living (ADLs) without difficulty, and
  • have no life-threatening conditions or diseases that would alter body composition from what is typical for age, sex, ethnicity, and BMI.

Exclusion Criteria

  • any internal metal artifact (e.g. pacemakers, internal fixation, arthroplasty), amputation, physical impairment or previous fracture that would alter body composition assessment
  • Pregnant or breastfeeding. (All premenopausal females will be asked for a spot urine sample for pregnancy test prior to participation. Those unwilling to comply with this will not be included.

Outcomes

Primary Outcomes

Fasting glucose levels

Time Frame: 1 day

Measure fasting glucose levels

Fat mass by MRI

Time Frame: 1 day

Measure fat mass and percent fat (arms, legs, trunk, visceral, and total) using MRI data

Fat mass by DXA

Time Frame: 1 day

Measure fat mass and percent fat (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data

Bone mass by DXA

Time Frame: 1 day

Measure bone mass (arms, legs, lumbar spine, and total) and Bone Mineral Density (spine and total) using Dual energy X-ray absorptiometry (DXA) data

Automatic 3D optical (3DO) scan measurement

Time Frame: 1 day

Automated 3DO measurement generated across the body

Lean mass by MRI

Time Frame: 1 day

Measure lean mass (arms, legs, trunk, and total) using MRI data

Waist to Hip ratio (WHR) from manual tape measurement

Time Frame: 1 day

Manual physical anthropometry of waist and hip circumferences

Hand-grip strength

Time Frame: 1 day

Measured by using a hand-grip dynamometer (JAMAR) as a measure of strength and physical capacity.

Isokinetic peak torque

Time Frame: 1 day

Measure the peak torque value (FT-LBS) generated during isokinetic knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

Lean mass by DXA

Time Frame: 1 day

Measure lean mass (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data

Isometric peak torque

Time Frame: 1 day

Measure the peak torque value (FT-LBS) generated during isometric knee extension/flexion movement evaluation at 60 degrees will be assessed with the HUMAC NORM device

Fasting HbA1c levels

Time Frame: 1 day

Measure fasting HbA1c levels

Fasting insulin levels

Time Frame: 1 day

Measure fasting insulin levels

Fasting cholesterol levels

Time Frame: 1 day

Measure fasting cholesterol levels

Fasting triglycerides levels

Time Frame: 1 day

Measure fasting triglycerides levels

Secondary Outcomes

  • Systolic and Diastolic blood pressure levels will be assessed(24 weeks)
  • Changes in isometric peak torque(24 weeks)
  • Changes in WHR(24 weeks)
  • Changes in isokinetic peak torque(24 weeks)
  • Body circumference from 2D imaging(24 weeks)
  • Changes in lean mass(24 weeks)
  • Changes in automatic 3DO scan measurement(24 weeks)
  • Fat loss(24 weeks)
  • Total Body Water(24 weeks)
  • Diet History Questionnaire II(24 weeks)
  • Phase angle(24 weeks)
  • Percent body fat(24 weeks)

Study Sites (3)

Loading locations...

Similar Trials